Gil Kaplan1, Remo Panaccione. Show Affiliations » 1. Inflammatory Bowel Disease Clinic, Division of Gastroenterology, Department of Medicine, University of Calgary, Alberta, Canada.
Abstract
Mesh： See more » Anti-Inflammatory Agents/adverse effectsAnti-Inflammatory Agents/therapeutic useDrug SynergismDrug Therapy, Combination/adverse effectsDrug Therapy, Combination/methodsHumansImmunomodulationImmunosuppressive Agents/adverse effectsImmunosuppressive Agents/therapeutic useInflammatory Bowel Diseases/drug therapyInflammatory Bowel Diseases/epidemiologyInflammatory Bowel Diseases/pathologyRemission InductionSecondary PreventionSeverity of Illness IndexTreatment Outcome
Substances： See more » Anti-Inflammatory AgentsImmunosuppressive Agents
Year: 2008 PMID： 18816768 DOI： 10.1002/ibd.20688
Source DB: PubMed Journal: Inflamm Bowel Dis ISSN： 1078-0998 Impact factor: 5.325